Week 3 - Endocrine, GI and Nutritional disorders Flashcards

1
Q

Risk factors for constipation

A
  • Female
  • Physical inactivity
  • Low education/income
  • Polypharmacy
  • Comorbidity
  • Depression
  • Poor dietary intake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of constipation

A
  • Pain, bloating, gas, infrequent defecation, straining, incomplete evacuation
  • Functional constipation – (2+ symptoms of…): straining, lumpy hard stools, sensation of incomplete evacuation, digital maneuvers to relieve symptoms, sensation of obstruction or blockage with 25% of BMs, decrease in stool frequency (less than 3 per week). Should be present for 3+ months consecutively with symptom onset at least 6 months prior to diagnosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Primary causes of constipation

A
  • Slow transit
  • Difficulty expelling stool from rectum
  • IBS-C (abdo pain and altered bowel habits)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Secondary causes of constipation

A
  • Malignancy
  • medications
  • DM
  • hypo/hyperthyroidism
  • parkinsons
  • stroke
  • dementia
  • malabsorption
  • scleroderma
  • depression
  • eating disorder
  • alcohol/substance abuse
  • anatomical dysfunction
  • decreased mobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Diagnosing constipation

A
  • Rectal exam, history, CBC, serum calcium, thyroid function test, fecal occult blood testing
  • No evidence for routine lab testing without a change in symptoms
  • Evaluation for fecal impaction with abdominal xray (iusually not able to assess with rectal exam)
  • Xray also indicated for megacolon, volvulus, mass lesion

Endoscopy only for:
* Colonic lesions, mass, obstruction. Volvulus, megacolon, strictures or mucosal biopsy for inflammation or microscopic colitis
 Specialized testing to diagnose constipation and fecal incontinence
* Motility or colonic transit studies
* Anorectal manometry – measures internal and external anal sphincter pressure at rest and during contraction.
* Rectal balloon – evaluate sensation and rectal capacity
* Endoanal ultrasound – evaluates for structural defects with internal/external anal sphincters
* Defecography – evaluates defectaory process after barium paste inserted rectally and patient defecates under fluoroscopy (assess rectal emptying and structural abnormalities of the pelvic floor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Non-pharmacological treatment for constipation

A
  • Regular bowel pattern
  • Exercise to increase motility
  • Water/fluid intake (91 ounces fluid/food)
  • Avoid excess straining
  • Increase fiber intake slowing *(5g/day at 1-week intervals until 25-30g fiber daily
  • Probiotics
  • Dyssynergia defecation (muscles and nerves in pelvic floor fail to coordinate correctly to have BM) treated with biofeedback
  • Bowel retraining
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacological treatment for constipation

A

Bulk forming laxatives– expand with water to increase fecal mass and softer stools

Sufficient water to avoid worsening of constipation or creating impaction. May inhibit absorption of some drugs (1 hour before or 2 hours after other meds)

Stool softeners and emollients – deterrent effect on stool consistency Does not interfere with other medicat5ions. Used when bulking agents don’t work or are not preferred, can be used in combo with bulking agents

Osmotic laxatives – promote secretion of water into the intestinal lumen by iostmotic activity (miralax, lactulose -less effective than miralax)
* Use in caution with CHF and CKD due to the risk of fluid/electrolyte imbalance

Stimulants – increase peristaltic contractions (senna, bisacodyl)

Suppositories/enemas – used when oral agents are not effective

**Chloride channel activators **
* Lubiprostone – improve intestinal motility by increasing intestinal fluid secretion without altering serum electrolytes.
* Guanylate cyclase C receptor agonists – linaclotice/plecanatide – stimulate intestinal fluid secretion and transit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fecal incontinence

A

Involuntary loss of liquid or solid stool that is a social or hygienic problem
o Fecal and urinary symptoms should always be evaluated together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nonpharmacological treatments for fecal incontinence

A
  • Avoid diet triggers for loose stool – lactose containing products,
  • increase dietary fiber
  • Bowel habit training and scheduled toileting w/ or w/o laxatives

Biofeedback – trained provider who uses an instrument with visual or auditor feedback on proper control of voluntary muscle contraction and relaxation of the external anal sphincter and recognition of anal sphincter sensation – improve sensation and muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Types of fecal incontinence

A
  • Urgency – strong urge and unable to hold stool in rectal vault
  • Passive – bowel leakage without sensation to defecate, seepage after BM, inability to discriminate gas/stool
  • Overflow – seepage around impaction, common in older immobile adults
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pharmacological treatments for fecal incontinence

A
  • Loperamide – watch for constipation
  • Cholestyramine when the above not effective
  • Perianal injection of dextranomer microspheres and hyaluronic acid
  • Sacral neuromodulation – percutaneous tibial nerve stimulation (PTENS) – stimulate defecation nerves 12 week sof treatment
  • Surgery – anal sphincter repair, artificial sphincter, colostomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment for fecal impaction

A
  • Results from lack of ability to sense and respond to stool in the rectum
  • Abdominal xray will help identify, digital rectum exam can be used but not always effective
  • Digital disimpaction to fragment a large amount of feces, should be followed by warm water enema with mineral oil to soften and assist with evacuation
  • Local anesthesia to relax anal canal and abdominal massage
  • Rare cases colonoscopy with snare to fragment fecal material
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sarcopenia

A

decreased muscle mass for age, sex, race

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Frailty

A

age related decline in reserve and function across multiple physiological systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Xerostomia

A

dry mouth – can be due to decreased saliva production (medications)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dysphagia

A

difficulty chewing and swallowing. Increases the risk for malnutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Components of nutrition assessment

A

Mini-Nutrition assessment/DETERMINE checklist

Measurements
* BMI, weight, weight changes, skinfold measurements

Labs
* CBC, protein status, C-reactive protein, lipids, electrolytes, BUN/creatinine
* Low albumin or prealbumin may instead indicate illness and inflammation rather than nutritional status. Experts recommend interpreting albumin levels based on CRP. If CRP is normal and albumin is low, then the low albumin may suggest low protein status

Clinical eval
* PE, chronic conditions, health status, oral health, polypharmacy

Dietary history and current intake
* Preferences, culture, frequency, control over selection/choices, fluid/alcohol intake, special diet, vitamin use, functional problems (chewing, feeding, cognitive change)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Two of the following elements needed to diagnose malnutrition

A
  • Insufficient energy intake
  • Weight loss
  • Loss of muscles mass
  • Loss of SQ fat
  • Localized/generalized fluid accumulation
  • Diminished functional status by handgrip strength
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Management of malnutrition

A
  • Treat underlying cause of malnutrition
  • Increase macronutrient (protein, carb, fat) intake
  • Appetite stimulant may be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Cancer management

A
  • Local treatment – surgery (safe into 90s) and radiation (used for palliation of pain and obstruction)
  • Systemic treatment – chemo, hormonal therapy (aromatase inhibitors are now treatment of choice – can cause osteoporosis), targeted therapy
  • Prostate cancer – gonadotropin-releasing hormone analogs
  • SERM (selective estrogen receptor modulator)– tamoxifen and raloxifene – prevent osteoporosis but have a risk for VTE
  • AI (aromatase inhibitors) anastrozole, letrozole, exemestane - can cause osteoporosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Common side effects of chemo in older adults

A
  • Alopecia
  • Anemia
  • Depression
  • Delirium
  • Diarrhea
  • Cardiotoxicity
  • Fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Workup for colorectal cancer

A
  • Colonoscopy
  • CT chest, abdo, pelvis
  • PET scan for mets
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Prostate cancer

A
  • Active surveillance for 70+ with a well differentiated tumor
  • Hormonal treatment for metastatic disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Staging for colon cancer

A
  • Stage I, T1T2, is limited to mucosa and submucosa (resection)
  • Stage IIA, invades muscularis propria (resection)
  • stage IIB invades the outer layer of colon proper, the serosa (fluorouracil and leucovorin)
  • Stage III is any lymph node involvement. (fluorouracil and leucovorin)
  • Stage IV involves distant metastases, typically the liver, regional abdominal lymph nodes, or lung because of the lymphatic drainage of the large bowel’’
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Causes of dysphagia

A
  • Systemic disorders
  • primary GI inflammatory/motility disorders
  • medication side effects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Symptoms of oropharyngeal dysphagia

A
  • Coughing, choking, nasopharyngeal regurgitation, aspiration, retained food in mouth
  • Reduced tongue strength, reduced wall contraction, decreased saliva, impaired gag reflex, poor dentition, neurological disorders (parkinson’s, alzheimers, myesthenia gravis), malignancies, zenker diverticulum, prominent osteophytes
27
Q

Symptoms of esophageal dysphagia

A
  • Sensation of food getting stuck in the esophagus several seconds after swallowing
  • Decreased saliva, altered motility, medications
  • Structural disorders
  • Motility disorders
  • Inflammatory/infectious disease
28
Q

Dysphagia that moves from solids and progresses to liquids OR rapid progression is concerning for…

A

Malignancy

29
Q

Dysphagia with odynophagia (painful swallowing) is indicative of…

A

infection viral or fungal (candida)

30
Q

Diagnosing dysphagia

A
  • Barium esophagram to identify diverticula, strictures and motility abnormalities
  • EGD
31
Q

Treatment for GERD

A

Hiatal hernia repair and nissen fundoplication

32
Q

Causes of peptic ulcer disease

A

Chronic NSAID us and H. pylori

33
Q

Most commonly affected ethnicity for DM

A

Black and hispanic

34
Q

Diagnostic criteria for DM

A
  • A1C 6.5% or higher
  • FBG 126mg/dL or greater–> 2 readings needed to diagnose
  • 2-hour BG during OGTT 200mg/dl or greater
  • Random BG 200mg/dL or greater
  • When classic symptoms of hyperglycemia or hyperglycemic crisis are present
35
Q

Lifestyle changes for DM diagnosis

A
  • Weight loss with caution
  • Exercise – resistance & aerobic – 150 min moderate exercise per week
36
Q

Pharmacological treatment for DM

A
  • Biguanides (metformin)
  • Sulfonylureas (glipizide)
  • GLP1 Agents (exenatide, liraglutide)
  • Sodium glucose transport 2 inhibitors (canagliflozin, dapaglifzolin_
  • DPP-4 inhibitor (Sitagliptin, linagliptin, saxagliptin)
37
Q

Insulin for DM management

A

o Indicated for patients who have not responded to diet and exercise an oral agents
o Need good functionality to monitor levels and hypos indepdendently
o can be given in long acting form once daily
o glargine or detemir insulin (
o if transitioning from a sulfonylurea to insulin need clear plan for taper and DC of sulfonylurea

38
Q

Biguanides

A

Metformin

Decreases hepatic production and intestinal absorption of glucose while improving insulin sensitivity
* Do not use with an eGFR of less than 30

39
Q

Sulfonylureas

A

Glipizide

Enhance beta cell secretion of insulin from the pancreas causing decrease in glucose output from the liver and increase in insulin sensitivity

40
Q

GLP1 Agents

A

Examples: exenatide, liraglutide

  • Intestinal hormone that stimulates the release of insulin as glucose rises in the postprandial period
  • Unlikely to cause hypoglycemia
  • Adjunct for glucose control in older adults
41
Q

Sodium glucose transport 2 inhibitors

A

Canagliflozin, dapaglifzolin

  • Increase urinary elimination of glucose
  • Can lower blood pressure and weight
  • Can cause orthostatic hypotension, increase in yeast and UTIs. Lowers the risk of CV events
42
Q

DPP-4 inhibitor

A

Sitagliptin, linagliptin, saxagliptin
* Block the breakdown of GLP1
* Does not cause hypoglydemia

43
Q

Metformin side effects

A
  • GI discomfort
  • Diarrhea
  • Decreased appetite
  • Weight loss
44
Q

Sulfonylureas side effects

A

Example: glipizide

  • Hypoglycemia
  • Weight gain
  • Skin rash/photosensitivity
45
Q

Side effects of DPP-4 inhibitors

A

Example: Saxagliptin

  • Severe skin rash
  • Angioedema if combined with ACE
46
Q

Side effects of GLP-1 agents

A

Example: liraglutide

  • N/V
  • Tachycardia
  • Acute pancreatitis
47
Q

Diabetic treatment priorities for older adults

A

Managing hypertension goal of <140/80  reduce by 20mmHg at a time)
* ACE / ARB preferred as they slow progression of proteinemia and nephropathy

Smoking cessation

Eye care for diabetic retinopathy
* New onset patient should have an eye exam annually (high risk), biennial (low risk}

Nephropathy
* Annual screening and at diagnosis
* BP and glucose control to slow progression
* Ace inhibitors delay progression

  • Neuropathies
     Foot exam yearly
     Gabapentin and pregabalin

Falls/fractures
 Gait abnormalities
 Altersed sense of vibration
 Neuropathy
 Foot deformities
 Orthostatic hypotension
 Decreased ankle dorsiflextion
 Muscle weakeness

Cognition

48
Q

HbA1c goals for older adults

A
  • A1c<7.5% for adults with good health (fasting BG 90-130—140/90)
  • A1c 8-8.5% for multiple comorbidities and minimizes risk for hypoglycemia (fasting BG 90-150 –140/90)
  • 8.5% for those with limited life expectancy and severe functional impairment (fasting BG 100-180—150/90)
49
Q

Hypoglycemia risk factors

A
  • Poor intake
  • Changes in mental status
  • Polypharmacy/medication non-compliance
  • Dependence or isolation
  • Impaired renal or hepatic metabolism
  • Presence of comorbid conditions that can mask symptoms (dementia, delirium, depression, sleep abnormalities, seizures, MI, CVA)
  • Other endocrine disorders (adrenal insufficiency)
50
Q

Diabetes risk factors

A
  • Age>65
  • Hispanic
  • BMI >25
  • Hypertension
  • Thiazide diuretic
51
Q

How to minimize diabetic macrovascular complications

A
  • BP management
  • Lipid management
52
Q

Microvascular complications

A
  • Nephropathy – routine urinalysis – albumin and creatinine clearance
  • Retinopathy- yearly eye exam
  • Peripheral neuropathy
53
Q

Annual checks for diabetics

A
  • HbA1c
  • lipid panel
  • BP
  • urine check
  • diabetic foot exam
  • flu shot
  • eye exam
54
Q

Diabetic checks done at every visit

A
  • Weight
  • BP
  • review blood sugars
  • review medications
55
Q

Symptoms of hypothyroidism

A
  • Fatigue
  • Weakness
  • Depression
  • Dry skin
  • Significantly less common in elders:
  • Weight gain
  • Cold intolerance
  • Muscle cramps
  • Paresthesia’s
  • Libido
  • Appetite
  • Arthralgias
  • Confusion
  • Constipation
  • Brittle nails
  • Loss of hair
  • Easy bruisability
  • Low back discomfort
  • Periorbital edema
  • Lipid abnormalities
  • general slowing of mental and physical function, cold intolerance, weight gain, constipation, effects on blood pressure, and anemia.
  • Older adults have less symptoms
56
Q

Diagnosing hypothyroidism

A

TSH (high), free T4 (low), free T3 (low)
* If acutely ill, test may be inaccurate – be sure to recheck 2-4 weeks after infection occurs

57
Q

Treatment for hypothyroidism

A

If patient is symptomatic and labs indicate hypothyroidism start with:
* Initial dose – 12.5-25mcg daily, recheck 4-6 weeks and adjust dose

  • If patient has CAD and will be on it long term then do cardiac stress test should be done

Overtreating can lead to osteoporosis in women

58
Q

Signs and symptoms of hyperthyroidism

A

Younger patients
* tachycardia, goiter, eye symptomology, diarrhea, sweating, agitation, anxiety

Older patients
* tachycardia, weight loss, apathy, fatigue, constipation

Thyroid storm symptoms
- a rapid heartbeat.
a high temperature.
- high blood pressure (hypertension)
- yellowing of the skin and eyes (jaundice)
- severe agitation and confusion.
- loss of consciousness.

59
Q

Diagnosing hyperthyroidism

A

TSH (low) T3 (high), T4 (high)

60
Q

Treatment for hyperthyroidism

A
  • Propylthiouracil OR methimazole
  • Beta blocker
  • Stabilize with above therapy, then radioactive iodine treatment (monitor for hypothyroidism)
61
Q

Hashimoto’s disease

A

Hypothyroidism

Cell mediated autoimmune inflammatory process

Results from irradiation, surgical removal of thyroid, pituitary and hypothalamic disorders causing TSH deficiencies, iodine induced (amiodarone, lithium, contrast dye, antithyroid drugs)

Most common form of hypothyroidism

62
Q

Grave’s disease

A

Autoimmune disorder resulting in hyperthyroidism.

Multinodular or unimodular goiter

63
Q

Subclinical hypothyroidism

A

o Mildly elevated TSH, normal free T4,
o No guidelines for treatment without evidence of symptoms

64
Q
A